Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acidosis
Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
Acidosis
Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation.
Acidosis
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
Acidosis
[Stimulation of gluconeogenic capacity in partially hepatectomized rats (author's transl)]
Acidosis, Lactic
An algorithmic approach to diagnosis of hypoglycemia.
Acidosis, Lactic
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Acidosis, Lactic
Hypovitaminosis D in glycogen storage disease type I.
Acidosis, Lactic
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Acidosis, Lactic
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Acidosis, Lactic
Problems in the congenital lactic acidoses.
Acidosis, Lactic
[Neutropenia in glycogenesis I B]
Acute Kidney Injury
[Activity of glycolysis key enzymes in subcellular structures of normal kidneys and under acute renal insufficiency]
Adenocarcinoma
Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.
Adenocarcinoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Adenocarcinoma
Sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine.
Adenocarcinoma
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]
Adenocarcinoma of Lung
Establishment and characteristics of a human lung adenocarcinoma cell line.
Adenoma
A case of glycogen storage disease type Ia with multiple hepatic adenomas and G727T mutation in the glucose-6-phosphatase gene, and a comparison with other mutations previously reported.
Adenoma
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Adenoma
Development of liver tumors in transforming growth factor alpha transgenic mice.
Adenoma
Hepatic preneoplasia in hepatitis B virus transgenic mice.
Adenoma
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Adenoma
Orthotopic liver transplantation in glucose-6-phosphatase deficiency--Von Gierke disease--with multiple hepatic adenomas and concomitant focal nodular hyperplasia.
Adenoma, Bile Duct
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.
Adenoma, Liver Cell
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.
Adenoma, Liver Cell
Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
Adenoma, Liver Cell
Unusual histochemical pattern in preneoplastic hepatic foci characterized by hyperactivity of several enzymes.
Adrenoleukodystrophy
Metabolic disorders in children.
Alopecia
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Alzheimer Disease
Caffeoylquinic acids with potential biological activity from plant in vitro cultures as alternative sources of valuable natural products.
Anaphylaxis
Morphochemical investigations of the liver and biochemical studies of the blood of guinea pigs in anaphylactic shock.
Anemia, Hemolytic
Acute haemolytic anaemia in glucose-6-phosphatase dehydrogenase deficient children.
Asbestosis
Biochemical mechanisms in asbestos toxicity.
Ataxia
Lack of coordination between glucose-6-phosphatase and gamma glutamyltranspeptidase activities in rat hepatocytes maintained in primary culture.
Bacterial Infections
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Bacterial Infections
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.
Brain Ischemia
Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia.
Breast Neoplasms
Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
Carcinogenesis
Changes in the activities of glucose-6-phosphatase, aldolase, and alkaline phosphatase during azo-dye carcinogenesis.
Carcinogenesis
Cytochemical localization and biochemical analysis of the enzyme markers in human hepatoma cell lines.
Carcinogenesis
Cytoplasmic changes in level and distribution of glucose-6-phosphatase activities from rat liver during diethylnitrosamine-induced carcinogenesis.
Carcinogenesis
Demonstration of glucose 6-phosphatase activity in the oval cells of rat liver and the significance of the oval cells in azo dye carcinogenesis.
Carcinogenesis
Enzyme pattern and growth rate of liver preneoplastic clones during carcinogenesis by diethylnitrosamine.
Carcinogenesis
Glucose-6-phosphatase activity in rat liver parenchyma during azo-dye carcinogenesis.
Carcinogenesis
Histochemical studies of glucose-6-phosphatase activity in the early proliferative stage of liver carcinogenesis.
Carcinogenesis
Nucleolar succinate dehydrogenase & glucose-6-phosphatase activities during hepatocellular carcinogenesis in thioacetamide fed rat.
Carcinogenesis
[Comparative study of glucose-6-phosphatase loss and serologic specificity in rat liver cells during incipient carcinogenesis]
Carcinogenesis
[Glucose-6-phosphatase activity and the effect on this activity of some inductors at different stages of liver carcinogenesis]
Carcinogenesis
[Glucose-6-phosphatase activity in liver carcinogenesis and in transplantable murine hepatomas]
Carcinoma
Carbohydrate metabolism in human renal clear cell carcinomas.
Carcinoma
Correlative histochemical studies on preneoplastic and neoplastic lesions in the kidney of rats treated with nitrosamines.
Carcinoma
Development of liver tumors in transforming growth factor alpha transgenic mice.
Carcinoma
Differential expression of the subunits of the glucose-6-phosphatase system in the clear cell type of human renal cell carcinoma - no evidence for an overexpression of protein kinase B.
Carcinoma
Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus.
Carcinoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Carcinoma
Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.
Carcinoma
Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
Carcinoma
Sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine.
Carcinoma
[Behavior of glucose-6-phosphatase & acid & alkaline phosphatases in the Ehrlich solid carcinoma.]
Carcinoma
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]
Carcinoma
[Submicroscopic localization of glucose-6-phosphatase in leukoplakia and carcinoma of the oral cavity]
Carcinoma, Ehrlich Tumor
Comparison of Ehrlich ascites tumour and mouse liver cells by analytical subcellular fractionation combined with a sensitive computational method for data analysis.
Carcinoma, Ehrlich Tumor
Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Carcinoma, Hepatocellular
A case of minimal deviation hepatoma in man with elevated liver-type pyruvate kinase isozyme.
Carcinoma, Hepatocellular
A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin.
Carcinoma, Hepatocellular
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Carcinoma, Hepatocellular
Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers, hepatomas, and hepatoma cell cultures.
Carcinoma, Hepatocellular
Adiponectin represses gluconeogenesis independent of insulin in hepatocytes.
Carcinoma, Hepatocellular
Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade.
Carcinoma, Hepatocellular
An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes.
Carcinoma, Hepatocellular
Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes.
Carcinoma, Hepatocellular
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
Carcinoma, Hepatocellular
Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family.
Carcinoma, Hepatocellular
Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a).
Carcinoma, Hepatocellular
Changes in the glucose-6-phosphatase complex in hepatomas.
Carcinoma, Hepatocellular
Cloning and sequencing of the 5' region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells.
Carcinoma, Hepatocellular
Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line.
Carcinoma, Hepatocellular
Construction and characterization of a conditionally active construct of the insulin-regulated forkhead transcription factor FKHR.
Carcinoma, Hepatocellular
Correlation between growth rate and cytochemistry in Morris hepatomas.
Carcinoma, Hepatocellular
Coupling of glucose response element from L-type pyruvate kinase and G6Pase promoter enhances glucose responsive activity in hepatoma cells.
Carcinoma, Hepatocellular
Cytochemical localization and biochemical analysis of the enzyme markers in human hepatoma cell lines.
Carcinoma, Hepatocellular
Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells.
Carcinoma, Hepatocellular
Distribution of glucose-6-phosphatase activity in normal, hyperplastic, and preneoplastic rat liver.
Carcinoma, Hepatocellular
Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.
Carcinoma, Hepatocellular
DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.
Carcinoma, Hepatocellular
Effect of insulin on the induction by dexamethasone of glucose-6-phosphohydrolase and translocase activities in cultured hepatoma cells.
Carcinoma, Hepatocellular
Effect of Morris 7777 hepatoma on microsomal glucose-6-phosphatase latent activity.
Carcinoma, Hepatocellular
Effects of catechin-rich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells.
Carcinoma, Hepatocellular
Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.
Carcinoma, Hepatocellular
Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Carcinoma, Hepatocellular
Enhanced Trimethylation of Histone H3 Mediates Impaired Expression of Hepatic Glucose 6-Phosphatase Expression in Offspring From Rat Dams Exposed to Hypoxia During Pregnancy.
Carcinoma, Hepatocellular
Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens.
Carcinoma, Hepatocellular
Enzyme histochemical phenotypes in primary hepatocellular carcinomas.
Carcinoma, Hepatocellular
Evaluation of the antidiabetic potential of Psidium guajava L. (Myrtaceae) using assays for ?-glucosidase, ?-amylase, muscle glucose uptake, liver glucose production, and triglyceride accumulation in adipocytes.
Carcinoma, Hepatocellular
Evidence for an indirect transcriptional regulation of glucose-6-phosphatase gene expression by liver X receptors.
Carcinoma, Hepatocellular
FACTORS INFLUENCING GLUCOSE-6-PHOSPHATASE ACTIVITY IN THE LIVER IN TRANSPLANTABLE CHRYSOIDIN HEPATOMA IN MICE.
Carcinoma, Hepatocellular
Glucose-6-phosphatase activity in regenerating cholangiole cells and hepatoma cells.
Carcinoma, Hepatocellular
Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells.
Carcinoma, Hepatocellular
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Carcinoma, Hepatocellular
Hepatic preneoplasia in hepatitis B virus transgenic mice.
Carcinoma, Hepatocellular
Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
Carcinoma, Hepatocellular
Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma.
Carcinoma, Hepatocellular
HISTOCHEMICAL DEMONSTRATION OF GLUCOSE-6-PHOSPHATASE IN TRANSPLANTABLE CHRYSOIDIN-INDUCED HEPATOMA.
Carcinoma, Hepatocellular
Hypoglycemic effects of brassinosteroid in diet-induced obese mice.
Carcinoma, Hepatocellular
Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells.
Carcinoma, Hepatocellular
Importance of Hepatocyte Nuclear Factor 4? in Glycerol-induced Glucose-6-phosphatase Expression in Liver.
Carcinoma, Hepatocellular
Induction of glucokinase mRNA by dietary phenolic compounds in rat liver cells in vitro.
Carcinoma, Hepatocellular
Induction of glucose 6-phosphatase in cultured hepatoma cells by dexamethasone.
Carcinoma, Hepatocellular
Inhibition of Glycogen Synthase Kinase-3? by Falcarindiol Isolated from Japanese Parsley (Oenanthe javanica).
Carcinoma, Hepatocellular
Insulin and epidermal growth factor suppress basal glucose-6-phosphatase catalytic subunit gene transcription through overlapping but distinct mechanisms.
Carcinoma, Hepatocellular
Intestinal glucose-dependent expression of glucose-6-phosphatase: involvement of the aryl receptor nuclear translocator transcription factor.
Carcinoma, Hepatocellular
Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP.
Carcinoma, Hepatocellular
Lead (Pb) exposure promotes diabetes in obese rodents.
Carcinoma, Hepatocellular
Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.
Carcinoma, Hepatocellular
Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism.
Carcinoma, Hepatocellular
Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells.
Carcinoma, Hepatocellular
Modulating effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in aflatoxin B1-induced experimental hepatocellular carcinoma.
Carcinoma, Hepatocellular
Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
Carcinoma, Hepatocellular
Phenolic Diterpenes from Rosemary Suppress cAMP Responsiveness of Gluconeogenic Gene Promoters.
Carcinoma, Hepatocellular
Phorbol ester-induced activation of mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase and extracellular-signal-regulated protein kinase decreases glucose-6-phosphatase gene expression.
Carcinoma, Hepatocellular
Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha.
Carcinoma, Hepatocellular
Potential markers (enzymes, proteoglycans) for human liver tumors.
Carcinoma, Hepatocellular
Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine.
Carcinoma, Hepatocellular
Regulation of glucose-6-phosphatase gene expression by insulin and metformin.
Carcinoma, Hepatocellular
Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.
Carcinoma, Hepatocellular
Rev-erb? activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
Carcinoma, Hepatocellular
Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo.
Carcinoma, Hepatocellular
Some peculiar biological and biochemical properties of a mouse hepatoma induced by chrysoidin. III. Activity of glucose-6-phosphatase.
Carcinoma, Hepatocellular
Structural constraints and importance of caffeic acid moiety for anti-hyperglycemic effects of caffeoylquinic acids from chicory.
Carcinoma, Hepatocellular
The comparative enzymology and cell origin of rat hepatomas. II. Glutamate dehydrogenase, choline oxidase, and glucose-6-phosphatase.
Carcinoma, Hepatocellular
The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements.
Carcinoma, Hepatocellular
The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis.
Carcinoma, Hepatocellular
The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
Carcinoma, Hepatocellular
Thioacetamide-induced hepatocarcinoma in rat.
Carcinoma, Hepatocellular
Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.
Carcinoma, Hepatocellular
Ultracytochemical localization of glucose-6-phosphatase in Chang rat hepatoma in vivo and in vitro.
Carcinoma, Hepatocellular
Use of protein-mediated lipid exchange in the study of membrane-bound enzymes. The lipid dependence of glucose-6-phosphatase.
Carcinoma, Hepatocellular
[Carbohydrate metabolism enzymatic activity and its alteration under the influence of thyroid hormone during tumor growth]
Carcinoma, Hepatocellular
[Change in the structure of glucose-6-phosphatase in Zajdela ascitic hepatoma cells]
Carcinoma, Hepatocellular
[FDG-PET in hepatocellular carcinoma. Based on one case]
Carcinoma, Hepatocellular
[Glucose-6-phosphatase activity in liver carcinogenesis and in transplantable murine hepatomas]
Carcinoma, Hepatocellular
[Noradrenaline and glycogen content and the activity of several enzymes of carbohydrate metabolism in normal, embryonic, and partly denervated livers and in hepatomas of the rat]
Carcinoma, Hepatocellular
[Photodynamic action of hypocrellin A on hepatoma cell mitochondria and microsomes]
Carcinoma, Hepatocellular
[Study of lipid dependence of glucose-6-phosphatase from rat liver and hepatoma using lipid exchange proteins]
Carcinoma, Renal Cell
Differential expression of the subunits of the glucose-6-phosphatase system in the clear cell type of human renal cell carcinoma - no evidence for an overexpression of protein kinase B.
Carcinoma, Squamous Cell
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Cardiotoxicity
Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities.
Chemical and Drug Induced Liver Injury
[Effect of Arnica montana tincture on some hydrolytic enzyme activities of rat liver in experimental toxic hepatitis]
Chemical and Drug Induced Liver Injury
[Phosphatidylcholine-induced repair of damaged hepatocyte membranes in heliotrine poisoning]
Cholecystitis
Liver involvement in cholecystitis and in obstructive icterus. A study with special reference to hexobarbital metabolism and glucose-6-phosphatase activity of human liver microsomes.
Cholestasis
Evaluation of key gluconeogenic enzymes in experimental biliary obstruction.
Cholestasis
Liver metabolic zonation in rat biliary cirrhosis: distribution is reverse of that in toxic cirrhosis.
Choriocarcinoma
The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
Coccidiosis
[Synthesis of glucose-6-phosphatase in small intestine mucosa during experimental coccidiosis in suckling piglets]
Conjunctivitis
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Crohn Disease
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Cysts
Some enzymes of gluconeogenesis in various fractions of sarcocysts of Sarcocystis fusiformis of buffalo (Bubalus bubalis).
Cysts
[Submicroscopic localization of glucose-6-phosphatase in the walls of dental cysts]
Dementia
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia.
Diabetes Mellitus
Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level.
Diabetes Mellitus
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
Diabetes Mellitus
Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice.
Diabetes Mellitus
Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose 6-phosphatase, glucose cycling and insulin release.
Diabetes Mellitus
Investigation of repressive and enhancive effects of fruit extracts on the activity of glucose-6-phophatase.
Diabetes Mellitus
Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Diabetes Mellitus
Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
Diabetes Mellitus
Phenolic Diterpenes from Rosemary Suppress cAMP Responsiveness of Gluconeogenic Gene Promoters.
Diabetes Mellitus
The glucose-6-phosphatase system in human development.
Diabetes Mellitus, Experimental
Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase.
Diabetes Mellitus, Experimental
Hormonal factors affecting glucose 6-phosphatase activity. 2. Some effects of diet and of alloxan diabetes in the rat.
Diabetes Mellitus, Experimental
[Behavior of renal glucose-6-phosphatase in experimental alloxan diabetes in rats]
Diabetes Mellitus, Experimental
[On the appearance of glucose-6-phosphatase in the pancreas of the white rat during alloxan diabetes]
Diabetes Mellitus, Type 1
A SNP in G6PC2 predicts insulin secretion in type 1 diabetes.
Diabetes Mellitus, Type 1
Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas.
Diabetes Mellitus, Type 1
Autoantigen Recognition Is Required for Recruitment of IGRP206-214-Autoreactive CD8+ T Cells but Is Dispensable for Tolerance.
Diabetes Mellitus, Type 1
DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8+ T cells independently of PD-1 and PD-L1.
Diabetes Mellitus, Type 1
Deletion of the G6pc2 gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein does not affect the progression or incidence of type 1 diabetes in NOD/ShiLtJ mice.
Diabetes Mellitus, Type 1
Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype.
Diabetes Mellitus, Type 1
Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression.
Diabetes Mellitus, Type 1
Genetic Variability of GCKR Alters Lipid Profiles in Children with Monogenic and Autoimmune Diabetes.
Diabetes Mellitus, Type 1
Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells.
Diabetes Mellitus, Type 1
Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Diabetes Mellitus, Type 1
Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein-Reactive CD4+ T Cells in Human Subjects.
Diabetes Mellitus, Type 1
Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo.
Diabetes Mellitus, Type 1
Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
Diabetes Mellitus, Type 1
Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
Diabetes Mellitus, Type 1
Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
Diabetes Mellitus, Type 2
A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.
Diabetes Mellitus, Type 2
A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin.
Diabetes Mellitus, Type 2
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
Diabetes Mellitus, Type 2
Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence.
Diabetes Mellitus, Type 2
Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Diabetes Mellitus, Type 2
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
Diabetes Mellitus, Type 2
Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes.
Diabetes Mellitus, Type 2
G6PC2 Modulates Fasting Blood Glucose In Male Mice in Response to Stress.
Diabetes Mellitus, Type 2
Gene-gene interactions lead to higher risk for development of type 2 diabetes in a Chinese Han population: a prospective nested case-control study.
Diabetes Mellitus, Type 2
Glucose-6-Phosphatase and ?-Glucosidase Inhibitors from Smilax moranensis Roots Identified by Affinity-Directed Fractionation.
Diabetes Mellitus, Type 2
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes.
Diabetes Mellitus, Type 2
Glucotoxicity Induces Glucose-6-Phosphatase Catalytic Unit Expression by Acting on the Interaction of Hypoxia Inducible Factor-1? With cAMP-Responsive Element-Binding Protein-Binding Protein.
Diabetes Mellitus, Type 2
Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 Diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis.
Diabetes Mellitus, Type 2
Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.
Diabetes Mellitus, Type 2
Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein.
Diabetes Mellitus, Type 2
Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
Diabetes Mellitus, Type 2
Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Diabetes Mellitus, Type 2
Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Diabetes Mellitus, Type 2
Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes.
Diabetes Mellitus, Type 2
Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients.
Diabetes Mellitus, Type 2
New In Vitro Studies on the Bioprofile of Genista tenera Antihyperglycemic Extract.
Diabetes Mellitus, Type 2
Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
Diabetes Mellitus, Type 2
STAT3 targets the regulatory regions of gluconeogenic genes in vivo.
Diabetes Mellitus, Type 2
Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection.
Diabetes Mellitus, Type 2
The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase.
Diabetes Mellitus, Type 2
The beta cell in NIDDM: giving light to the blind.
Diabetes Mellitus, Type 2
The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perfused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase.
Diabetes Mellitus, Type 2
The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects.
Diabetes Mellitus, Type 2
Transcriptional regulation of glucose-6-phosphatase catalytic subunit promoter by insulin and glucose in the carnivorous fish, Sparus aurata.
Diabetes Mellitus, Type 2
Von Gierke's disease adopts an orphan (and its partner).
Diabetes Mellitus, Type 2
[The role of arecoline on hepatic insulin resistance in type 2 diabetes rats].
Diabetic Nephropathies
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
dipeptidyl-peptidase iv deficiency
Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytes.
Diverticulum
Identification, expression and regulation of amphioxus G6Pase gene with an emphasis on origin of liver.
Dyslipidemias
Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
Dyslipidemias
Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase.
Dyslipidemias
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Endometrial Neoplasms
Therapeutic potential of riboflavin, niacin and ascorbic Acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.
Endometrial Neoplasms
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
Fabry Disease
Rapid molecular diagnosis of genetic diseases by high resolution melting analysis: fabry and glycogen storage 1A diseases.
Fanconi Syndrome
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
Fanconi Syndrome
[The Fanconi-Bickel syndrome]
Fatty Liver
Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.
Fatty Liver
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.
Fatty Liver
N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
Fetal Growth Retardation
Enhanced Trimethylation of Histone H3 Mediates Impaired Expression of Hepatic Glucose 6-Phosphatase Expression in Offspring From Rat Dams Exposed to Hypoxia During Pregnancy.
Fetal Growth Retardation
Fructose-1,6-diphosphatase and glucose-6-phosphatase in newborn rats with intrauterine growth retardation.
Fetal Growth Retardation
Placenta of idiopathic fetal growth restriction: cytochemically detectable enzyme activities do not change at a subcellular level.
Fetal Growth Retardation
[Effect of intrauterine growth retardation on gluconeogenic enzymes in rat liver].
Focal Nodular Hyperplasia
Orthotopic liver transplantation in glucose-6-phosphatase deficiency--Von Gierke disease--with multiple hepatic adenomas and concomitant focal nodular hyperplasia.
Focal Nodular Hyperplasia
Potential markers (enzymes, proteoglycans) for human liver tumors.
Fructose Intolerance
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Gallstones
Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.
Gallstones
Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones.
Genetic Diseases, Inborn
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.
Genetic Diseases, Inborn
Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.
Genetic Diseases, Inborn
Cell death and stress signaling in glycogen storage disease type I.
Genetic Diseases, Inborn
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Genetic Diseases, Inborn
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Genetic Diseases, Inborn
[Biological and physiopathological aspects of hepatic glycogenoses]
Glioblastoma
Glucose-6-phosphatase is a Key Metabolic Regulator of Glioblastoma Invasion.
Glucose Intolerance
18?-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism.
Glucose Intolerance
A high-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db mice.
Glucose Intolerance
Comparative Effects of the Renin-Angiotensin System Blockers on Nonalcoholic Fatty Liver Disease and Insulin Resistance in C57Bl/6 Mice.
Glucose Intolerance
Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure.
Glucose Intolerance
Dietary P(i) deprivation in rats affects liver cAMP, glycogen, key steps of gluconeogenesis and glucose production.
Glucose Intolerance
Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.
Glucose Intolerance
Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis.
Glucose Intolerance
Hepatic overexpression of dominant negative Mlx improves metabolic profile in diabetes-prone C57BL/6J mice.
Glucose Intolerance
Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions.
Glucose Intolerance
Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
Glucose Intolerance
The Impact of Genetic Variation in the G6PC2 Gene on Insulin Secretion Depends on Glycemia.
Glucose Intolerance
Up-regulation of liver glucose-6-phosphatase in rats fed with a P(i)-deficient diet.
Glucose Metabolism Disorders
A new mechanism of POCD caused by sevoflurane in mice: cognitive impairment induced by cross-dysfunction of iron and glucose metabolism.
glucose-6-phosphatase deficiency
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.
glucose-6-phosphatase deficiency
A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case.
glucose-6-phosphatase deficiency
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a.
glucose-6-phosphatase deficiency
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
glucose-6-phosphatase deficiency
AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
glucose-6-phosphatase deficiency
An algorithmic approach to diagnosis of hypoglycemia.
glucose-6-phosphatase deficiency
Analysis of the albino-locus region of the mouse: IV. Characterization of 34 deficiencies.
glucose-6-phosphatase deficiency
Candidate polymorphisms and severe malaria in a malian population.
glucose-6-phosphatase deficiency
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
glucose-6-phosphatase deficiency
Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
glucose-6-phosphatase deficiency
Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy.
glucose-6-phosphatase deficiency
Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
glucose-6-phosphatase deficiency
Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
Defect of platelet function associated with chronic hypoglycaemia.
glucose-6-phosphatase deficiency
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
glucose-6-phosphatase deficiency
Disorders associated with purine and pyrimidine metabolism.
glucose-6-phosphatase deficiency
FDG PET/CT in Type I Glycogen Storage Disease.
glucose-6-phosphatase deficiency
Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.
glucose-6-phosphatase deficiency
Generation of mice with a conditional allele for G6pc.
glucose-6-phosphatase deficiency
Glucose 6-phosphatase deficiency: mechanisms of genetic control and biochemistry.
glucose-6-phosphatase deficiency
Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.
glucose-6-phosphatase deficiency
Glucose-6-phosphatase deficiency and hyperlipaemia.
glucose-6-phosphatase deficiency
Glucose-6-phosphatase deficiency caused by radiation-induced alleles at the albino locus in the mouse.
glucose-6-phosphatase deficiency
Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.
glucose-6-phosphatase deficiency
Glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells.
glucose-6-phosphatase deficiency
Glycogenosis type IB: possible membrane transport defect.
glucose-6-phosphatase deficiency
Hepatic adenomata with type 1 glycogen storage disease.
glucose-6-phosphatase deficiency
Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
glucose-6-phosphatase deficiency
Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome.
glucose-6-phosphatase deficiency
Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.
glucose-6-phosphatase deficiency
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
glucose-6-phosphatase deficiency
Human microsomal glucose-6-phosphatase system.
glucose-6-phosphatase deficiency
Hydropericardium causing sudden infant death in glycogenosis type I: osmotic injury due to percutaneous silastic catheterization.
glucose-6-phosphatase deficiency
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
glucose-6-phosphatase deficiency
Impaired platelet function in glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.
glucose-6-phosphatase deficiency
Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
glucose-6-phosphatase deficiency
Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
glucose-6-phosphatase deficiency
Learning from claims: hyperbilirubinaemia and kernicterus.
glucose-6-phosphatase deficiency
Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.
glucose-6-phosphatase deficiency
Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
glucose-6-phosphatase deficiency
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
glucose-6-phosphatase deficiency
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
glucose-6-phosphatase deficiency
Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
glucose-6-phosphatase deficiency
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
glucose-6-phosphatase deficiency
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
glucose-6-phosphatase deficiency
Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia.
glucose-6-phosphatase deficiency
Regulation of liver metabolism by the endosomal GTPase Rab5.
glucose-6-phosphatase deficiency
Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism.
glucose-6-phosphatase deficiency
Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.
glucose-6-phosphatase deficiency
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
glucose-6-phosphatase deficiency
The gene for glycogen-storage disease type 1b maps to chromosome 11q23.
glucose-6-phosphatase deficiency
The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice.
glucose-6-phosphatase deficiency
The lactate concentration of the urine, a parameter for the adequacy of dietary treatment of patients with glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
The molecular basis of the type 1 glycogen storage diseases.
glucose-6-phosphatase deficiency
The molecular basis of type 1 glycogen storage diseases.
glucose-6-phosphatase deficiency
The prenatal determination of glucose-6-phosphatase activity by fetal liver biopsy.
glucose-6-phosphatase deficiency
The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice.
glucose-6-phosphatase deficiency
The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
glucose-6-phosphatase deficiency
Urate production in heterozygotes for glucose-6-phosphatase deficiency.
glucose-6-phosphatase deficiency
[A case of Gierke's disease]
glucose-6-phosphatase deficiency
[Definition and classification of hyperuricemia]
glucose-6-phosphatase deficiency
[Late manifestation of glycogenosis I in early adulthood]
glucose-6-phosphatase deficiency
[Late manifestations of glycogenosis 1 in early adulthood]
glucose-6-phosphatase deficiency
[Treatment of glycogen storage diseases]
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Glucose-6-phosphatase and glucose-6-phosphate dehydrogenase deficiency: how are they different?
Glucosephosphate Dehydrogenase Deficiency
Glucose-6-phosphatase and glucose-6-phosphate dehydrogenase deficiency: how are they different?
glycerol-3-phosphate dehydrogenase deficiency
The beta cell in NIDDM: giving light to the blind.
Glycogen Storage Disease
11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function.
Glycogen Storage Disease
3'-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and Glycogen Storage Disease type-Ia risk.
Glycogen Storage Disease
A case of glycogen storage disease type Ia with multiple hepatic adenomas and G727T mutation in the glucose-6-phosphatase gene, and a comparison with other mutations previously reported.
Glycogen Storage Disease
A case of type Ia glycogen storage disease complicated by hepatic adenoma.
Glycogen Storage Disease
A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging.
Glycogen Storage Disease
A common 2 bp deletion mutation in the glucose-6-phosphatase gene in Indian patients with glycogen storage disease type Ia.
Glycogen Storage Disease
A conformational model for the human liver microsomal glucose-6-phosphatase system: evidence from rapid kinetics and defects in glycogen storage disease type 1.
Glycogen Storage Disease
A detailed characterization of the adult mouse model of glycogen storage disease Ia.
Glycogen Storage Disease
A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia.
Glycogen Storage Disease
A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Glycogen Storage Disease
A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system.
Glycogen Storage Disease
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a.
Glycogen Storage Disease
A new variant of glycogen storage disease type 1: probably due to a defect in the glucose-6-phosphate transport system.
Glycogen Storage Disease
A novel DraI polymorphism in the 3' untranslated region of human glucose-6-phosphatase gene: useful for carrier detection and prenatal diagnosis of glycogen storage disease type 1a.
Glycogen Storage Disease
A novel mutation in the glucose-6-phosphatase gene in Korean twins with glycogen storage disease type Ia.
Glycogen Storage Disease
A novel type heterozygous mutation in the glucose-6-phosphatase gene in a Chinese patient with glycogen storage disease Ia.
Glycogen Storage Disease
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.
Glycogen Storage Disease
AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
Glycogen Storage Disease
AAV-MEDIATED CORRECTION OF A CANINE MODEL OF GLYCOGEN STORAGE DISEASE TYPE IA.
Glycogen Storage Disease
Abdominal imaging findings of a patient with hepatocellular carcinoma associated with glycogen storage disease type 1a.
Glycogen Storage Disease
Acoustic accessibility investigation for ultrasound mediated treatment of glycogen storage disease type ia patients.
Glycogen Storage Disease
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Glycogen Storage Disease
Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats.
Glycogen Storage Disease
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Glycogen Storage Disease
Asparagine-linked oligosaccharides are localized to a luminal hydrophilic loop in human glucose-6-phosphatase.
Glycogen Storage Disease
Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia.
Glycogen Storage Disease
Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.
Glycogen Storage Disease
Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia).
Glycogen Storage Disease
Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia.
Glycogen Storage Disease
Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family.
Glycogen Storage Disease
Cell death and stress signaling in glycogen storage disease type I.
Glycogen Storage Disease
Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab.
Glycogen Storage Disease
Clinical and biochemical findings before and after portacaval shunt in a girl with type Ib glycogen storage disease.
Glycogen Storage Disease
Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
Glycogen Storage Disease
Clinical and enzymological studies in a child with type I glycogen storage disease associated with partial deficiency of hepatic glucose-6-phosphatase.
Glycogen Storage Disease
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Glycogen Storage Disease
Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
Glycogen Storage Disease
Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy.
Glycogen Storage Disease
Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.
Glycogen Storage Disease
Continuous glucose monitoring in children with glycogen storage disease type I.
Glycogen Storage Disease
Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Glycogen Storage Disease
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Glycogen Storage Disease
Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors.
Glycogen Storage Disease
Demonstration of a metabolically active glucose-6-phosphate pool in the lumen of liver microsomal vesicles.
Glycogen Storage Disease
Dietary management of Type I glycogen storage disease.
Glycogen Storage Disease
Disturbed lipid metabolism in glycogen storage disease type 1.
Glycogen Storage Disease
Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Iotaa.
Glycogen Storage Disease
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
Glycogen Storage Disease
Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease.
Glycogen Storage Disease
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia.
Glycogen Storage Disease
Emerging therapies for glycogen storage disease type I.
Glycogen Storage Disease
Exercise capacity and biochemical profile during exercise in patients with glycogen storage disease type I.
Glycogen Storage Disease
Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan.
Glycogen Storage Disease
FDG PET/CT in Type I Glycogen Storage Disease.
Glycogen Storage Disease
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Glycogen Storage Disease
Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression.
Glycogen Storage Disease
Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.
Glycogen Storage Disease
Gene therapy for type I glycogen storage diseases.
Glycogen Storage Disease
Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a.
Glycogen Storage Disease
Genetic analysis of the glucose-6-phosphatase mutation of type 1a glycogen storage disease in a Chinese family.
Glycogen Storage Disease
Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus.
Glycogen Storage Disease
Genetic evidence for the common identity of glucose-6-phosphatase, pyrophosphate-glucose phosphotransferase, carbamyl phosphate-glucose phosphotransferase and inorganic pyrophosphatase.
Glycogen Storage Disease
Glucose 6-phosphate transport in fibroblast microsomes from glycogen storage disease type 1b patients: evidence for multiple glucose 6-phosphate transport systems.
Glycogen Storage Disease
Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.
Glycogen Storage Disease
Glucose-6-phosphatase and type 1 glycogen storage disease: some critical considerations.
Glycogen Storage Disease
Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.
Glycogen Storage Disease
Glucose-6-phosphatase deficiency.
Glycogen Storage Disease
Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse.
Glycogen Storage Disease
Glucose-6-phosphatase gene (727G-->T) splicing mutation is prevalent in Hong Kong Chinese patients with glycogen storage disease type 1a.
Glycogen Storage Disease
Glucose-6-phosphatase gene G327A mutation is common in Chinese patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.
Glycogen Storage Disease
Glucose-6-phosphatase gene mutations in Taiwan Chinese patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Glucose-6-phosphatase gene mutations in Turkish patients with glycogen storage disease type Ia.
Glycogen Storage Disease
GLUCOSE-6-PHOSPHATASE IN HUMAN JEJUNAL MUCOSA. LACK OF ACTIVITY IN GLYCOGENOSIS OF CORI'S TYPE 1.
Glycogen Storage Disease
Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype.
Glycogen Storage Disease
Glucose-6-phosphatase of the liver in glycogen storage disease.
Glycogen Storage Disease
Glycogen storage disease diagnosed in adults.
Glycogen Storage Disease
Glycogen storage disease of the liver; report of an atypical case with studies of the glycogen structure and the glucose-6-phosphatase activity of the liver.
Glycogen Storage Disease
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies.
Glycogen Storage Disease
Glycogen storage disease type 1a in three siblings with the G270V mutation.
Glycogen Storage Disease
Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
Glycogen Storage Disease
Glycogen storage disease type 1b due to a defect of glucose-6-phosphate translocase.
Glycogen Storage Disease
Glycogen storage disease type 1b: microsomal glucose-6-phosphatase system in two patients with different clinical findings.
Glycogen Storage Disease
Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.
Glycogen Storage Disease
Glycogen storage disease type I: laboratory data and diagnosis.
Glycogen Storage Disease
Glycogen storage disease type Ia (GSD Ia) during pregnancy: report of a case complicated by fetal growth restriction and preeclampsia.
Glycogen Storage Disease
Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability.
Glycogen Storage Disease
Glycogen storage disease type Ia: four novel mutations (175delGG, R170X, G266V and V338F) identified. Mutations in brief no. 220. Online.
Glycogen Storage Disease
Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
Glycogen Storage Disease
Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells.
Glycogen Storage Disease
Glycogen storage disease type Ia: molecular study in Brazilian patients.
Glycogen Storage Disease
Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart.
Glycogen Storage Disease
Glycogen storage disease type Ib without neutropenia.
Glycogen Storage Disease
Gouty tendinitis revealing glycogen storage disease Type Ia in two adolescents.
Glycogen Storage Disease
Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia.
Glycogen Storage Disease
Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
Glycogen Storage Disease
Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
Glycogen Storage Disease
Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.
Glycogen Storage Disease
Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
Glycogen Storage Disease
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Glycogen Storage Disease
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
Glycogen Storage Disease
Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector.
Glycogen Storage Disease
Heteroduplex analysis: a useful screening method for glycogen storage disease type Ia.
Glycogen Storage Disease
Heterogeneous mutations in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Historical highlights and unsolved problems in glycogen storage disease type 1.
Glycogen Storage Disease
Human microsomal glucose-6-phosphatase system.
Glycogen Storage Disease
Human variant glucose-6-phosphate transporter is active in microsomal transport.
Glycogen Storage Disease
Hydropericardium causing sudden infant death in glycogenosis type I: osmotic injury due to percutaneous silastic catheterization.
Glycogen Storage Disease
Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
Glycogen Storage Disease
Hypovitaminosis D in glycogen storage disease type I.
Glycogen Storage Disease
Identification of a novel missense mutation (T16A) in the glucose-6-phosphatase gene in a Taiwan Chinese patient with glycogen storage disease Ia (Von Gierke disease).
Glycogen Storage Disease
Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes.
Glycogen Storage Disease
Identification of a point mutation (G727T) in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type 1a, and carrier screening in healthy volunteers.
Glycogen Storage Disease
Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.
Glycogen Storage Disease
Identification of mutations in the glucose-6-phosphatase gene in Czech and Slovak patients with glycogen storage disease type ia, including novel mutations K76N, V166A and 540del5.
Glycogen Storage Disease
Identification of the human hepatic microsomal glucose-6-phosphatase enzyme.
Glycogen Storage Disease
Identification of three novel mutations (Q54P, W70X and T108I) in the glucose-6-phosphatase gene of patients with glycogen storage disease type Ia. Mutation in brief no. 256. Online.
Glycogen Storage Disease
Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB.
Glycogen Storage Disease
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.
Glycogen Storage Disease
In vivo evidence for defective activity of glucose-6-phosphatase in type IB glycogenosis.
Glycogen Storage Disease
In vivo hepatic lipid quantification using MRS at 7 Tesla in a mouse model of glycogen storage disease type 1a.
Glycogen Storage Disease
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.
Glycogen Storage Disease
Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.
Glycogen Storage Disease
Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia.
Glycogen Storage Disease
Infectious and bleeding complications in patients with glycogenosis Ib.
Glycogen Storage Disease
Intestinal function in glycogen storage disease type I.
Glycogen Storage Disease
Intestinal glucose-6-phosphatase in control subjects and relatives of a patient with glycogen storage disease.
Glycogen Storage Disease
Investigation of repressive and enhancive effects of fruit extracts on the activity of glucose-6-phophatase.
Glycogen Storage Disease
Is glycogen storage disease 1a associated with atherosclerosis?
Glycogen Storage Disease
Ischemic stroke in an adult with glycogen storage disease type I.
Glycogen Storage Disease
Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia.
Glycogen Storage Disease
Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A.
Glycogen Storage Disease
Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children.
Glycogen Storage Disease
Liver and liver cell transplantation for glycogen storage disease type IA.
Glycogen Storage Disease
Liver transplantation in glycogen storage disease type I.
Glycogen Storage Disease
Liver-specific glucose-6-phosphatase is not present in human placenta.
Glycogen Storage Disease
Living donor liver transplantation for glycogen storage disease type Ib.
Glycogen Storage Disease
Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer.
Glycogen Storage Disease
Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia.
Glycogen Storage Disease
Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
Glycogen Storage Disease
Molecular aspects of glycogen storage disease type Ia in Turkish patients: a novel mutation in the glucose-6-phosphatase gene.
Glycogen Storage Disease
Molecular diagnosis of type 1c glycogen storage disease.
Glycogen Storage Disease
Molecular genetic analysis of glycogen storage disease type Ia in 26 Chinese patients.
Glycogen Storage Disease
Molecular genetics of type 1 glycogen storage disease.
Glycogen Storage Disease
Molecular Genetics of Type 1 Glycogen Storage Diseases.
Glycogen Storage Disease
Molecular pathology of glucose-6-phosphatase.
Glycogen Storage Disease
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.
Glycogen Storage Disease
Mutation spectrum of glycogen storage disease type Ia in Tunisia: implication for molecular diagnosis.
Glycogen Storage Disease
Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Mutational spectrum and identification of five novel mutations in G6PC1 gene from a cohort of Glycogen Storage Disease Type 1a.
Glycogen Storage Disease
Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c.
Glycogen Storage Disease
Mutations in the glucose-6-phosphatase gene of 53 Italian patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a.
Glycogen Storage Disease
Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.
Glycogen Storage Disease
NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
Glycogen Storage Disease
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.
Glycogen Storage Disease
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
Glycogen Storage Disease
Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type Ia.
Glycogen Storage Disease
New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Glycogen Storage Disease
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Glycogen Storage Disease
Ontogeny of the murine glucose-6-phosphatase system.
Glycogen Storage Disease
Oral manifestations in glycogen storage disease type 1b.
Glycogen Storage Disease
Oxidative stress mediates nephropathy in type Ia glycogen storage disease.
Glycogen Storage Disease
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Glycogen Storage Disease
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Glycogen Storage Disease
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Possibilities for the cytochemical diagnosis of enzymopathies.
Glycogen Storage Disease
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Glycogen Storage Disease
Preemptive liver-kidney transplantation in von Gierke disease: a case report.
Glycogen Storage Disease
Prenatal diagnosis in a Chinese family with type Ia glycogen storage disease by PCR-based genetic analysis.
Glycogen Storage Disease
Prenatal diagnosis of glycogen storage disease type 1a by single stranded conformation polymorphism (SSCP).
Glycogen Storage Disease
Prenatal diagnosis of glycogen storage disease type Ia by restriction enzyme digestion.
Glycogen Storage Disease
Prenatal diagnosis of glycogen storage disease type Ia, presenting a new mutation in the glucose-6-phosphatase gene.
Glycogen Storage Disease
Proton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib.
Glycogen Storage Disease
Rapid height growth after liver transplantation in adulthood.
Glycogen Storage Disease
Rapid molecular diagnosis of genetic diseases by high resolution melting analysis: fabry and glycogen storage 1A diseases.
Glycogen Storage Disease
Rapid screening of 12 common mutations in Turkish GSD 1a patients using electronic DNA microarray.
Glycogen Storage Disease
Renal complications in glycogen storage disease type I.
Glycogen Storage Disease
Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism.
Glycogen Storage Disease
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
Glycogen Storage Disease
Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
Glycogen Storage Disease
Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
Glycogen Storage Disease
SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.
Glycogen Storage Disease
Simultaneous liver-kidney transplantation for glycogen storage disease type IA (von Gierke's disease).
Glycogen Storage Disease
Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings.
Glycogen Storage Disease
Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.
Glycogen Storage Disease
STUDIES IN GLYCOGEN STORAGE DISEASES. I. INTESTINAL GLUCOSE-6-PHOSPHATASE ACTIVITY IN PATIENTS WITH VON GIERKE'S DISEASE AND THEIR PARENTS.
Glycogen Storage Disease
Studies on a patient with in vivo evidence of type I glycogenosis and normal enzyme activities in vitro.
Glycogen Storage Disease
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
Glycogen Storage Disease
The carbohydrate response element binding protein (ChREBP) and not the liver X receptor ? (LXR?) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
Glycogen Storage Disease
The glucose-6-phosphatase system in human development.
Glycogen Storage Disease
The glucose-6-phosphatase system.
Glycogen Storage Disease
The human embryonic-fetal kidney endoplasmic reticulum phosphate-pyrophosphate transport protein.
Glycogen Storage Disease
The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase.
Glycogen Storage Disease
The molecular basis of the genetic deficiencies of five of the components of the glucose-6-phosphatase system: improved diagnosis.
Glycogen Storage Disease
The molecular basis of the type 1 glycogen storage diseases.
Glycogen Storage Disease
The molecular basis of type 1 glycogen storage diseases.
Glycogen Storage Disease
The rs2229611 (G6PC:c.*23 T>C) is associated with glycogen storage disease type Ia in Brazilian patients.
Glycogen Storage Disease
Transmembrane topology of glucose-6-phosphatase.
Glycogen Storage Disease
Transmembrane topology of human glucose 6-phosphate transporter.
Glycogen Storage Disease
Two new mutations in the glucose-6-phosphatase gene cause glycogen storage disease in Hungarian patients.
Glycogen Storage Disease
Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.
Glycogen Storage Disease
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Glycogen Storage Disease
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Glycogen Storage Disease
Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system.
Glycogen Storage Disease
Type Ib glycogenosis.
Glycogen Storage Disease
Type La glycogen storage disease with focal nodular hyperplasia in siblings.
Glycogen Storage Disease
Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene.
Glycogen Storage Disease
Unreliability of platelet glucose-6-phosphatase for the diagnosis of glycogen storage disease type Ia.
Glycogen Storage Disease
Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
Glycogen Storage Disease
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Glycogen Storage Disease
[Biological and physiopathological aspects of hepatic glycogenoses]
Glycogen Storage Disease
[Carbohydrates in the treatment of glycogenoses]
Glycogen Storage Disease
[Clinical and molecular genetic analysis for a patient with glycogen storage disease ?a].
Glycogen Storage Disease
[CONTRIBUTION TO THE METABOLISM OF ALPHA-KETO ACIDS IN GLYCOGENOSIS WITH GLUCOSE-6-PHOSPHATASE INSUFFICIENCY.]
Glycogen Storage Disease
[Genetic heterogeneity and the diagnosis of hepatic glycogenoses]
Glycogen Storage Disease
[Glycogen storage disease type I with normal in vitro activity of glucose-6-phosphatase (author's transl)]
Glycogen Storage Disease
[Glycogenoses type 1b and 1c]
Glycogen Storage Disease
[Hepatic glycogenoses. Correlations between the clinical and biochemical characteristics and the type of enzymatic deficiency: glucose-6-phosphatase, amylo-1-6-glucosidase, phosphorylase.]
Glycogen Storage Disease
[Hepatic glycogenoses. Introduction]
Glycogen Storage Disease
[Hepatic glycogenosis caused by glucose-6-phosphatase associated with a thrombopathy.]
Glycogen Storage Disease
[Heterogeneous phenotypes in Chinese glycogen storage disease type Ia patients with homozygous G727T mutation]
Glycogen Storage Disease
[ON A SPECIAL FORM OF GIERKE'S GLYCOGENOSIS WITH INCREASED ALPHA-GLUCOSIDASE ACTIVITY IN THE LIVER AND COMPLETE LACK OF GLUCOSE-6-PHOSPHATASE.]
Glycogen Storage Disease
[The Fanconi-Bickel syndrome]
Glycogen Storage Disease
[Treatment of glycogen storage diseases]
Glycogen Storage Disease Type I
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.
Glycogen Storage Disease Type I
A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case.
Glycogen Storage Disease Type I
A new model for the membrane topology of glucose-6-phosphatase: the enzyme involved in von Gierke disease.
Glycogen Storage Disease Type I
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a.
Glycogen Storage Disease Type I
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Glycogen Storage Disease Type I
AAV-MEDIATED CORRECTION OF A CANINE MODEL OF GLYCOGEN STORAGE DISEASE TYPE IA.
Glycogen Storage Disease Type I
Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.
Glycogen Storage Disease Type I
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Glycogen Storage Disease Type I
An algorithmic approach to diagnosis of hypoglycemia.
Glycogen Storage Disease Type I
Analysis of the albino-locus region of the mouse: IV. Characterization of 34 deficiencies.
Glycogen Storage Disease Type I
Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
Glycogen Storage Disease Type I
Candidate polymorphisms and severe malaria in a malian population.
Glycogen Storage Disease Type I
Cell death and stress signaling in glycogen storage disease type I.
Glycogen Storage Disease Type I
Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
Glycogen Storage Disease Type I
Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Glycogen Storage Disease Type I
Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
Continuous glucose monitoring in children with glycogen storage disease type I.
Glycogen Storage Disease Type I
Defect of platelet function associated with chronic hypoglycaemia.
Glycogen Storage Disease Type I
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
Glycogen Storage Disease Type I
Disorders associated with purine and pyrimidine metabolism.
Glycogen Storage Disease Type I
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia.
Glycogen Storage Disease Type I
Emerging therapies for glycogen storage disease type I.
Glycogen Storage Disease Type I
FDG PET/CT in Type I Glycogen Storage Disease.
Glycogen Storage Disease Type I
Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.
Glycogen Storage Disease Type I
Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.
Glycogen Storage Disease Type I
Glucose-6-phosphatase deficiency and hyperlipaemia.
Glycogen Storage Disease Type I
Glucose-6-phosphatase deficiency caused by radiation-induced alleles at the albino locus in the mouse.
Glycogen Storage Disease Type I
Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.
Glycogen Storage Disease Type I
Glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies.
Glycogen Storage Disease Type I
Glycogen storage disease type 1a in three siblings with the G270V mutation.
Glycogen Storage Disease Type I
Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells.
Glycogen Storage Disease Type I
Glycogenosis type IB: possible membrane transport defect.
Glycogen Storage Disease Type I
Hepatic adenomata with type 1 glycogen storage disease.
Glycogen Storage Disease Type I
Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome.
Glycogen Storage Disease Type I
Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
Glycogen Storage Disease Type I
Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.
Glycogen Storage Disease Type I
Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
Glycogen Storage Disease Type I
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Glycogen Storage Disease Type I
Heteroduplex analysis: a useful screening method for glycogen storage disease type Ia.
Glycogen Storage Disease Type I
Human microsomal glucose-6-phosphatase system.
Glycogen Storage Disease Type I
Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
Glycogen Storage Disease Type I
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
Glycogen Storage Disease Type I
Hypovitaminosis D in glycogen storage disease type I.
Glycogen Storage Disease Type I
Impaired platelet function in glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.
Glycogen Storage Disease Type I
Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
Glycogen Storage Disease Type I
Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
Intestinal function in glycogen storage disease type I.
Glycogen Storage Disease Type I
Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
Glycogen Storage Disease Type I
Ischemic stroke in an adult with glycogen storage disease type I.
Glycogen Storage Disease Type I
Learning from claims: hyperbilirubinaemia and kernicterus.
Glycogen Storage Disease Type I
Lipid storage myopathy in von Gierke's disease: a case report.
Glycogen Storage Disease Type I
Liver transplantation in glycogen storage disease type I.
Glycogen Storage Disease Type I
Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
Glycogen Storage Disease Type I
Molecular Genetics of Type 1 Glycogen Storage Diseases.
Glycogen Storage Disease Type I
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.
Glycogen Storage Disease Type I
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
Glycogen Storage Disease Type I
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Glycogen Storage Disease Type I
Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
Glycogen Storage Disease Type I
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Glycogen Storage Disease Type I
Platelet glucose-6-phosphatase activity in patients with von Gierke's disease and their parents.
Glycogen Storage Disease Type I
Preemptive liver-kidney transplantation in von Gierke disease: a case report.
Glycogen Storage Disease Type I
Preliminary studies of liver glucose-6-phosphatase in von Gierke's disease.
Glycogen Storage Disease Type I
Regulation of liver metabolism by the endosomal GTPase Rab5.
Glycogen Storage Disease Type I
Renal complications in glycogen storage disease type I.
Glycogen Storage Disease Type I
Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism.
Glycogen Storage Disease Type I
Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings.
Glycogen Storage Disease Type I
STUDIES IN GLYCOGEN STORAGE DISEASES. I. INTESTINAL GLUCOSE-6-PHOSPHATASE ACTIVITY IN PATIENTS WITH VON GIERKE'S DISEASE AND THEIR PARENTS.
Glycogen Storage Disease Type I
Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.
Glycogen Storage Disease Type I
The diagnostic value of thrombocytic glucose-6-phosphatase in patients with von Gierke's disease and its heterozygotes.
Glycogen Storage Disease Type I
The glucose-6-phosphatase system in human development.
Glycogen Storage Disease Type I
The lactate concentration of the urine, a parameter for the adequacy of dietary treatment of patients with glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
The molecular basis of the type 1 glycogen storage diseases.
Glycogen Storage Disease Type I
The molecular basis of type 1 glycogen storage diseases.
Glycogen Storage Disease Type I
The prenatal determination of glucose-6-phosphatase activity by fetal liver biopsy.
Glycogen Storage Disease Type I
The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice.
Glycogen Storage Disease Type I
The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
Two new mutations in the glucose-6-phosphatase gene cause glycogen storage disease in Hungarian patients.
Glycogen Storage Disease Type I
Type La glycogen storage disease with focal nodular hyperplasia in siblings.
Glycogen Storage Disease Type I
Urate production in heterozygotes for glucose-6-phosphatase deficiency.
Glycogen Storage Disease Type I
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Glycogen Storage Disease Type I
[A case of Gierke's disease]
Glycogen Storage Disease Type I
[Glycogen storage disease type I with normal in vitro activity of glucose-6-phosphatase (author's transl)]
Glycogen Storage Disease Type I
[Late manifestation of glycogenosis I in early adulthood]
Glycogen Storage Disease Type I
[Late manifestations of glycogenosis 1 in early adulthood]
Glycogen Storage Disease Type I
[Treatment of glycogen storage diseases]
Glycogen Storage Disease Type III
A case of limit dextrinosis (Cori's disease) with lowered activity of glucose-6-phosphatase.
Glycosuria
The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver.
Gout
A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case.
Gout
Clinical and enzymological studies in a child with type I glycogen storage disease associated with partial deficiency of hepatic glucose-6-phosphatase.
Gout
Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
Granuloma
Susceptibility of desert sheep to infection with Schistosoma mansoni of Northern Sudan.
Heart Defects, Congenital
G6PC3 Deficiency: Primary Immune Deficiency Beyond Just Neutropenia.
Heart Defects, Congenital
G6PC3 mutations cause non-syndromic severe congenital neutropenia.
Hepatitis
Changes in catalase and glucose-6-phosphatase distribution patterns within oval cell compartment as possible differentiation markers during viral hepatocarcinogenesis in woodchucks.
Hepatitis
Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma.
Hepatitis
Serum glucose-6-phosphatase activity in acute hepatitis.
Hepatitis
[Glucose-6-phosphatase in the liver of subject with acute viral hepatitis and cirrhosis.]
Hepatitis
[Studies on the behavior of the serum glucose-6-phosphatase activity in acute hepatitis]
Hepatitis B
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
Hepatitis, Chronic
[Features of the effect of bemethyl on glycogen metabolism in hepatocytes of pathological changed human liver]
Hepatolenticular Degeneration
Metabolic disorders in children.
Hepatomegaly
A 20-year follow-up of a male patient with type Ia glycogen storage disease.
Hepatomegaly
A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Hepatomegaly
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Hepatomegaly
Comparison of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate, and di(n-octyl) phthalate in rats.
Hepatomegaly
Diagnosis of type 1a and type 1c glycogen storage diseases in adults.
Hepatomegaly
Glucose-6-phosphatase deficiency.
Hepatomegaly
Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia.
Hepatomegaly
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Hepatomegaly
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Hepatomegaly
Problems in the congenital lactic acidoses.
Hepatomegaly
Regulation of liver metabolism by the endosomal GTPase Rab5.
Hepatomegaly
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
Hepatomegaly
SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.
Hepatomegaly
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
Hepatomegaly
The molecular basis of type 1 glycogen storage diseases.
Hepatomegaly
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Hepatomegaly
[Neutropenia in glycogenesis I B]
Herpes Zoster
The human adrenal microsomal glucose-6-phosphatase system.
Hodgkin Disease
Glucose-6-phosphatase activity of Reed-Sternberg and Hodgkin cells.
Huntington Disease
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia.
Hypercholesterolemia
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Hypercholesterolemia
Regulation of liver metabolism by the endosomal GTPase Rab5.
Hypercholesterolemia
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
Hypercholesterolemia
[Effect of whole-body vibration on glucose concentration and gluconeogenesis enzyme activity in the blood and tissues of rabbits with experimental hypercholesterolemia]
Hyperglycemia
A high-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db mice.
Hyperglycemia
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice.
Hyperglycemia
Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds.
Hyperglycemia
Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Hyperglycemia
Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica.
Hyperglycemia
Biochemical evidence on the potential role of organophosphates in hepatic glucose metabolism toward insulin resistance through inflammatory signaling and free radical pathways.
Hyperglycemia
Chronic effects of clozapine administration on insulin resistance in rats: evidence for adverse metabolic effects.
Hyperglycemia
Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Hyperglycemia
Common variants at ten genomic loci influence hemoglobin A1C levels via glycemic and non-glycemic pathways.
Hyperglycemia
Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice.
Hyperglycemia
Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase.
Hyperglycemia
Effect of diabetes on the rat hepatic glucose-6-phosphatase system in endoplasmic reticulum subfractions.
Hyperglycemia
Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression.
Hyperglycemia
Effects of tephrosia purpurea aqueous seed extract on blood glucose and antioxidant enzyme activities in streptozotocin induced diabetic rats.
Hyperglycemia
Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia.
Hyperglycemia
Evaluation of the antithyroid, antioxidative and antihyperglycemic activity of scopoletin from Aegle marmelos leaves in hyperthyroid rats.
Hyperglycemia
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
Hyperglycemia
G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting.
Hyperglycemia
Glucose 6-phosphate regulates hepatic glycogenolysis through inactivation of phosphorylase.
Hyperglycemia
Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats.
Hyperglycemia
Glucose utilization and anti-oxidative mechanisms of the aqueous hunteria umbellata seed extract in alloxan-induced diabetic rats.
Hyperglycemia
Hepatic ERK activity plays a role in energy metabolism.
Hyperglycemia
Hyperglycemia contributes to impaired insulin response in GK rat islets.
Hyperglycemia
Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.
Hyperglycemia
Influence of glibenclamide on the efficacy of calcium trisodium pentetat as an antidote for cadmium toxicity.
Hyperglycemia
Instant White Rice with Pigmented Giant Embryonic Rice Improves Glucose Metabolism and Inhibits Oxidative Stress in High-Fat Diet-Fed Mice.
Hyperglycemia
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Hyperglycemia
Lack of significant long-term effect of dietary carbohydrates on hepatic glucose-6-phosphatase expression in rainbow trout (Oncorhynchus mykiss).
Hyperglycemia
Liver-specific iNOS expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.
Hyperglycemia
Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice.
Hyperglycemia
Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
Hyperglycemia
Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
Hyperglycemia
Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat.
Hyperglycemia
Metabolism and fatty acid profile in fat and lean rainbow trout lines fed with vegetable oil: effect of carbohydrates.
Hyperglycemia
MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Hyperglycemia
Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice.
Hyperglycemia
Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions.
Hyperglycemia
Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
Hyperglycemia
Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Hyperglycemia
Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis.
Hyperglycemia
Royal jelly improves hyperglycemia in obese/diabetic KK-Ay mice.
Hyperglycemia
Salidroside improves glucose homeostasis in obese mice by repressing inflammation in white adipose tissues and improving leptin sensitivity in hypothalamus.
Hyperglycemia
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
Hyperglycemia
Specific reduction of G6PT may contribute to downregulation of hepatic 11?-HSD1 in diabetic mice.
Hyperglycemia
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance.
Hyperglycemia
The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase.
Hyperglycemia
The Impact of Genetic Variation in the G6PC2 Gene on Insulin Secretion Depends on Glycemia.
Hyperglycemia
The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes.
Hyperglycemia
Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet.
Hyperglycemia
Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats.
Hyperglycemia
[The effect of prenatal hyper- and hypoglycemia on liver mitochondrial function and carbohydrate metabolism in rat pups]
Hyperhomocysteinemia
[Effect of homocysteine on gluconeogenesis in mice].
Hyperinsulinism
Chronic hyperinsulinemia in the fetal rhesus monkey: effects of physiologic hyperinsulinemia on fetal substrates, hormones, and hepatic enzymes.
Hyperinsulinism
Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Hyperinsulinism
Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
Hyperinsulinism
Derangement in hepatic enzymes caused by sucrose-drinking and its implication for the development of hyperglycemia in female Wistar fatty rats.
Hyperinsulinism
Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice.
Hyperinsulinism
Hepatic insulin resistance induced by chronic hindlimb ischemia.
Hyperinsulinism
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Hyperinsulinism
Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat.
Hyperinsulinism
Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Hyperinsulinism
Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs.
Hyperinsulinism
Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.
Hyperinsulinism
Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis.
Hyperinsulinism
Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo.
Hyperinsulinism
Surgical removal of visceral fat reverses hepatic insulin resistance.
Hyperinsulinism
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance.
Hyperinsulinism
Vanillic acid mitigates the impairments in glucose metabolism in HepG2 cells through BAD-GK interaction during hyperinsulinemia.
Hyperlactatemia
Combined deficiency of glucose-6-phosphatase and fructose-1, 6-diphosphatase. Studies of glucagon secretion and fuel utilization.
Hyperlipidemias
A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Hyperlipidemias
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Hyperlipidemias
Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Hyperlipidemias
Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression.
Hyperlipidemias
Hypovitaminosis D in glycogen storage disease type I.
Hyperlipidemias
Placental permeability and energy metabolism enzymes in fetuses of lipemic rats.
Hyperlipidemias
Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.
Hyperlipidemias
Regulation of liver metabolism by the endosomal GTPase Rab5.
Hyperlipidemias
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
Hyperlipidemias
The molecular basis of type 1 glycogen storage diseases.
Hyperlipidemias
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Hyperlipidemias
[Neutropenia in glycogenesis I B]
Hypertension
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
Hypertension
[Endocrine-metabolic relations in rats with genetic arterial hypertension]
Hypertension
[Fundamental and applied studies on transport and metabolism of electrolytes and glucose--aim to contact with molecular biology]
Hypertension, Pulmonary
Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
Hyperthyroidism
Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats.
Hyperthyroidism
Evaluation of the antithyroid, antioxidative and antihyperglycemic activity of scopoletin from Aegle marmelos leaves in hyperthyroid rats.
Hyperthyroidism
Glucose turnover in hyperthyroid patients with normal glucose tolerance.
Hyperthyroidism
Response of hepatic glucokinase and glucose-6-phosphatase activities in juvenile and adult hyperthyroid mice.
Hypertriglyceridemia
Combined deficiency of glucose-6-phosphatase and fructose-1, 6-diphosphatase. Studies of glucagon secretion and fuel utilization.
Hypertriglyceridemia
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Hypertriglyceridemia
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Hypoglycemia
A central role of RLIP76 in regulation of glycemic control.
Hypoglycemia
A detailed characterization of the adult mouse model of glycogen storage disease Ia.
Hypoglycemia
A hypothesis linking hypoglycemia, hyperuricemia, lactic acidemia, and reduced gluconeogenesis in alcoholics to inactivation of glucose-6-phosphatase activity by acetaldehyde.
Hypoglycemia
AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
Hypoglycemia
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Hypoglycemia
Activation of liver G-6-Pase in response to insulin-induced hypoglycemia or epinephrine infusion in the rat.
Hypoglycemia
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Hypoglycemia
Alterations in glucose homeostasis in a murine model of chagas disease.
Hypoglycemia
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Hypoglycemia
Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia.
Hypoglycemia
Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep.
Hypoglycemia
Combined deficiency of glucose-6-phosphatase and fructose-1, 6-diphosphatase. Studies of glucagon secretion and fuel utilization.
Hypoglycemia
Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency.
Hypoglycemia
Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Hypoglycemia
CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis.
Hypoglycemia
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Hypoglycemia
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
Hypoglycemia
Effect of anabolic steroid, methylandrostenediol, on the intravenous insulin hypoglycemia and on liver glucose-6-phosphatase activity in male rats.
Hypoglycemia
Effect of gamma-hexachlorocyclohexane (lindane) on carp (Cyprinus carpio). II. Effects of chronic intoxication on blood, liver enzymes, and muscle plasmic membrane.
Hypoglycemia
Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease.
Hypoglycemia
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia.
Hypoglycemia
Enhanced gene expression of systemically administered plasmid DNA in the liver with therapeutic ultrasound and microbubbles.
Hypoglycemia
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Hypoglycemia
G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting.
Hypoglycemia
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Hypoglycemia
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
Hypoglycemia
Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene.
Hypoglycemia
Hypovitaminosis D in glycogen storage disease type I.
Hypoglycemia
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.
Hypoglycemia
Induction in utero of hepatic glucose-6-phosphatase by fetal hypoinsulinemia.
Hypoglycemia
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Hypoglycemia
Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase.
Hypoglycemia
Liver glucose-6-phosphatase activity and blood fatty acid level in rats with insulin-induced hypoglycemia.
Hypoglycemia
Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
Hypoglycemia
Long-Term Effects of Prenatal Severe Hypoxia on Central and Peripheral Components of the Glucocorticoid System in Rats.
Hypoglycemia
Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia.
Hypoglycemia
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
Hypoglycemia
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Hypoglycemia
Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.
Hypoglycemia
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Hypoglycemia
Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.
Hypoglycemia
Regulation of liver metabolism by the endosomal GTPase Rab5.
Hypoglycemia
Renal and biochemical changes produced in broilers by high-protein, high-calcium, urea-containing, and vitamin-A-deficient diets.
Hypoglycemia
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
Hypoglycemia
Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
Hypoglycemia
SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.
Hypoglycemia
Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.
Hypoglycemia
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
Hypoglycemia
Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia.
Hypoglycemia
The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through ROR? and SRC-2 coactivator transcriptional activity.
Hypoglycemia
The molecular basis of type 1 glycogen storage diseases.
Hypoglycemia
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Hypoglycemia
Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
Hypoglycemia
[Neutropenia in glycogenesis I B]
Hypoglycemia
[The effect of prenatal hyper- and hypoglycemia on liver mitochondrial function and carbohydrate metabolism in rat pups]
Hyponatremia
Effect of gamma-hexachlorocyclohexane (lindane) on carp (Cyprinus carpio). II. Effects of chronic intoxication on blood, liver enzymes, and muscle plasmic membrane.
Hypophosphatemia
Up-regulation of liver glucose-6-phosphatase in x-linked hypophosphatemic mice.
Hypotension
Alterations in hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and glucose-6-phosphatase gene expression after hemorrhagic hypotension and resuscitation.
Hypotension
Regulation of liver and kidney glucose-6-phosphatase gene expression in hemorrhage and resuscitation.
hypoxanthine phosphoribosyltransferase deficiency
Disorders associated with purine and pyrimidine metabolism.
Infections
Biochemical studies in the vole, Microtus montanus. II. The effects of a Trypanosoma brucei gambiense infection on the diurnal variation of hepatic glucose-6-phosphatase and liver glycogen.
Infections
Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a).
Infections
Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.
Infections
DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.
Infections
Effect of praziquantel on some aspects of carbohydrate metabolism in mice infected with Schistosoma mansoni.
Infections
Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection.
Infections
Isolation and partial characterization of plasma membranes from the livers of control and Streptococcus pneumoniae-infected rats.
Infections
Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders.
Infections
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Infections
[Posthepatic obstructive jaundice caused by primary extragonadal germ-cell tumor in a patient with glucose-6-phosphatase dehydrogenase deficiency].
Inflammatory Bowel Diseases
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Inflammatory Bowel Diseases
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Insulin Resistance
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice.
Insulin Resistance
Aging is associated with increased TRB3, ER stress, and hepatic glucose production in the liver of rats.
Insulin Resistance
Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
Insulin Resistance
Asthma alleviates obesity in males through regulating metabolism and energy expenditure.
Insulin Resistance
Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet.
Insulin Resistance
Beneficial effects of Aronia melanocarpa berry extract on hepatic insulin resistance in type 2 diabetes mellitus rats.
Insulin Resistance
Carbohydrate intolerance associated with reduced hepatic glucose phosphorylating and releasing enzyme activities and peripheral insulin resistance in alcoholics with liver cirrhosis.
Insulin Resistance
Central administration of vaspin inhibits glucose production and augments hepatic insulin signaling in high-fat-diet-fed rat.
Insulin Resistance
Chronic effects of clozapine administration on insulin resistance in rats: evidence for adverse metabolic effects.
Insulin Resistance
Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment.
Insulin Resistance
Deficiency in Interferon-{gamma} Results in Reduced Body Weight and Better Glucose Tolerance in Mice.
Insulin Resistance
Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Insulin Resistance
DHEA-induced modulation of renal gluconeogenesis, insulin sensitivity and plasma lipid profile in the control- and dexamethasone-treated rabbits. Metabolic studies.
Insulin Resistance
Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation.
Insulin Resistance
Effect of trivalent chromium on erythropoietin production and the prevention of insulin resistance in HepG2 cells.
Insulin Resistance
Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice.
Insulin Resistance
Effects of coffee on type 2 diabetes mellitus.
Insulin Resistance
Effects of fasting and refeeding on the activity of hepatic glucose-6-phosphatase in rats.
Insulin Resistance
Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.
Insulin Resistance
Effects of the Combined Extracts of Grape Pomace and Omija Fruit on Hyperglycemia and Adiposity in Type 2 Diabetic Mice.
Insulin Resistance
Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice.
Insulin Resistance
Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats.
Insulin Resistance
G6PC2: A Negative Regulator of Basal Glucose-Stimulated Insulin Secretion.
Insulin Resistance
Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
Insulin Resistance
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
Insulin Resistance
Hawthorn polyphenols, D-chiro-inositol, and epigallocatechin gallate exert a synergistic hypoglycemic effect.
Insulin Resistance
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance.
Insulin Resistance
Hepatic insulin resistance induced by chronic hindlimb ischemia.
Insulin Resistance
Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1? and dephosphorylation of FoxO1.
Insulin Resistance
High-Efficacy ?,?-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats.
Insulin Resistance
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
Insulin Resistance
Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.
Insulin Resistance
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.
Insulin Resistance
Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats.
Insulin Resistance
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Insulin Resistance
Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Insulin Resistance
Jiaogulan tea (Gpostemma pentaphyllum) potentiates the antidiabetic effect of white tea via the AMPK and PI3K pathways in C57BL/6 mice.
Insulin Resistance
Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.
Insulin Resistance
Mibefradil reduces hepatic glucose output in HepG2 cells via Ca2+/calmodulin-dependent protein kinase II-dependent Akt/forkhead box O1signaling.
Insulin Resistance
MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Insulin Resistance
Mitigating Perspectives of Asiatic acid in the Renal derangements of Streptozotocin-Nicotinamide induced Diabetic Rats.
Insulin Resistance
Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet.
Insulin Resistance
Phytomedicines Used for Diabetes Mellitus in Ghana: A Systematic Search and Review of Preclinical and Clinical Evidence.
Insulin Resistance
Renal Denervation Reverses Hepatic Insulin Resistance Induced by High-Fat Diet.
Insulin Resistance
SIK1 Regulates CRTC2-Mediated Gluconeogenesis Signaling Pathway in Human and Mouse Liver Cells.
Insulin Resistance
Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
Insulin Resistance
Small intestinal metabolism is central to whole-body insulin resistance.
Insulin Resistance
Specific reduction of G6PT may contribute to downregulation of hepatic 11?-HSD1 in diabetic mice.
Insulin Resistance
Surgical removal of visceral fat reverses hepatic insulin resistance.
Insulin Resistance
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.
Insulin Resistance
Transcription factor TIP27 regulates glucose homeostasis and insulin sensitivity in a PI3-kinase/Akt-dependent manner in mice.
Insulin Resistance
Up-regulation of liver glucose-6-phosphatase in rats fed with a P(i)-deficient diet.
Insulin Resistance
Zingiber mioga reduces weight gain, insulin resistance and hepatic gluconeogenesis in diet-induced obese mice.
Insulin Resistance
[Effect of intrauterine growth retardation on gluconeogenic enzymes in rat liver].
Insulin Resistance
[Increased expression of gluconeogenic enzymes in the liver of IUGR rats and subsequent insulin resistance]
Insulinoma
Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell lines.
Insulinoma
Expression of constructs between the glucose-6-phosphatase promoter and a reporter gene in an insulinoma cell line: regulation by glucose, dibutyryl cAMP and dexamethasone.
Insulinoma
Glucose induces glucose 6-phosphatase hydrolytic subunit gene transcription in an insulinoma cell line (INS-1).
Insulinoma
Glucose-6-phosphatase in the insulin secreting cell line INS-1.
Insulinoma
Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein.
Leptospirosis
Alterations in specific activity of glucose-6-phosphatase in laboratory rats after leptospiral exposure followed by triiodothyronine administration.
Leukemia
Liver glucose-6-phosphatase and carbohydrate metabolism in childhood leukemia.
Leukemia
REDUCED LIVER GLUCOSE-6-PHOSPHATASE IN HUMAN LEUKEMIA.
Leukemia
Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.
Leukemia
[Glucose-6-phosphatase activity in experimental tumors and leucocytes of human leukemias.]
Leukodystrophy, Globoid Cell
Metabolic disorders in children.
Leukoplakia
[Submicroscopic localization of glucose-6-phosphatase in leukoplakia and carcinoma of the oral cavity]
Liver Cirrhosis
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Liver Cirrhosis
Prevention of CCL4-induced liver cirrhosis by silymarin.
Liver Cirrhosis
Restoration of the glycogen-forming function of hepatocytes in rats with liver cirrhosis is facilitated by a high-carbohydrate diet.
Liver Cirrhosis
[Rehabilitation of the hepatocyte glycogen-forming function in the rat cirrhotic liver due to carbohydrate rich diet]
Liver Cirrhosis
[The glycogen-forming function of the hepatocytes during the regeneration of the cirrhotic rat liver after a partial hepatectomy]
Liver Diseases
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Liver Diseases
Pathological occurrence of glucose-6-phosphatase in serum in liver diseases.
Liver Diseases
[Studies on serum glucose-6-phosphatase activity of the liver in children. 4. On hepatic glucose-6-phosphatase activity level in congenital bile-duct atresia and other liver diseases in children.]
Liver Failure, Acute
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Liver Neoplasms
Expression of c-myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital.
Liver Neoplasms
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Liver Neoplasms, Experimental
Correlation between growth rate and cytochemistry in Morris hepatomas.
Lymphoma
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Lymphoma
Alterations in total iron, zinc, and calcium levels and their influence on the hepatic activities of gamma-glutamyl transferase and glucose-6-phosphatase in the host bearing transplantable murine lymphoma.
Lymphoma, B-Cell
Trace Mineral Overload Induced Hepatic Oxidative Damage and Apoptosis in Pigs with Long-Term High-Level Dietary Mineral Exposure.
Lymphopenia
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Magnesium Deficiency
Hepatic gluconeogenic enzymes, plasma insulin and glucagon response to magnesium deficiency and fasting.
Malaria
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Malnutrition
Evidence for liver energy metabolism programming in offspring subjected to intrauterine undernutrition during midgestation.
Melanoma
Cathepsin B: association with plasma membrane in metastatic tumors.
Melanoma
Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
Metabolic Diseases
Glucose-6-phosphatase deficiency.
Metabolic Diseases
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Metabolic Diseases
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Metabolic Syndrome
Association analysis of genetic variants with metabolic syndrome components in the Moroccan population.
Methemoglobinemia
Delayed Diagnosis in Army Ranger Postdeployment Primaquine-Induced Methemoglobinemia.
Methemoglobinemia
Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency: case report and literature review.
Myeloproliferative Disorders
Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia.
Neoplasm Metastasis
Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET.
Neoplasms
A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
Neoplasms
Abdominal imaging findings of a patient with hepatocellular carcinoma associated with glycogen storage disease type 1a.
Neoplasms
Alteration by phenobarbital of membrane-associated enzymes including gamma glutamyl transpeptidase in mouse liver neoplasms.
Neoplasms
Alterations in total iron, zinc, and calcium levels and their influence on the hepatic activities of gamma-glutamyl transferase and glucose-6-phosphatase in the host bearing transplantable murine lymphoma.
Neoplasms
Altered oxidative stress and carbohydrate metabolism in canine mammary tumors.
Neoplasms
Anti-Diabetic Effect of Trigonelline and Nicotinic Acid, on KK-A(y) Mice.
Neoplasms
Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice.
Neoplasms
Biochemical evidence on the potential role of organophosphates in hepatic glucose metabolism toward insulin resistance through inflammatory signaling and free radical pathways.
Neoplasms
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
Neoplasms
Changes in the cellular phenotype and extracellular matrix during progression of estrogen-induced mesenchymal kidney tumors in Syrian hamsters.
Neoplasms
Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell lines.
Neoplasms
Comparison of Ehrlich ascites tumour and mouse liver cells by analytical subcellular fractionation combined with a sensitive computational method for data analysis.
Neoplasms
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Neoplasms
Detection of a novel, primate-specific 'kill switch' tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53.
Neoplasms
Detection of a novel, primate-specific kill switch tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53
Neoplasms
Development of liver tumors in transforming growth factor alpha transgenic mice.
Neoplasms
Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Neoplasms
Effect of glutathione and N-acetylcysteine on hepatocellular modifications induced by 2-acetylaminofluorene.
Neoplasms
Effect of partial hepatectomy on tumor incidence and metabolism of mice fed thioacetamide.
Neoplasms
Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma.
Neoplasms
Effect of tumor necrosis factor on enzymes of gluconeogenesis in the rat.
Neoplasms
Effects of dietary energy on antioxidant capacity, glucose-lipid metabolism and meat fatty acid profile of Holstein bulls at different ages.
Neoplasms
Effects of female sex steroids on concanavalin A-mediated agglutination of hepatocytes from nonregenerating and regenerating rat liver and hepatic tumor marker enzymes.
Neoplasms
Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.
Neoplasms
Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens.
Neoplasms
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Neoplasms
Food Shortage Causes Differential Effects on Body Composition and Tissue-Specific Gene Expression in Salmon Modified for Increased Growth Hormone Production.
Neoplasms
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells.
Neoplasms
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase.
Neoplasms
Glucose phosphatase in benign and malignant tumours of the prostate. (Preliminary communication).
Neoplasms
Glucose-6-phosphatase activity in primary rat liver tumors induced by high doses of 4-dimethylaminoazo-benzene.
Neoplasms
Glucose-6-phosphatase and phosphorylase activities in mice bearing corticotropin-secreting tumors.
Neoplasms
Glucose-6-phosphatase as a marker for tumors of liver and kidney origin.
Neoplasms
Glucose-6-phosphatase Expression-Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models.
Neoplasms
Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.
Neoplasms
GLUCOSE-6-PHOSPHATASE: REEXAMINATION OF THE RNA-INDUCED ACTIVITY IN MOUSE ASCITES TUMOR CELLS.
Neoplasms
Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met.
Neoplasms
Histochemical characteristics of spontaneous and chemically induced hepatocellular neoplasms in mice and the development of neoplasms with gamma-glutamyl transpeptidase activity during phenobarbital exposure.
Neoplasms
Histochemistry of liver tumors induced by diethylnitrosamine and differential sex susceptibility to carcinogenesis in Oryzias latipes.
Neoplasms
Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study.
Neoplasms
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
Neoplasms
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Neoplasms
Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose.
Neoplasms
Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels.
Neoplasms
Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.
Neoplasms
Modification of DENA-induced hepatocarcinogenesis by CCl4 cirrhosis. Comparison of the marker enzyme patterns.
Neoplasms
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Neoplasms
Morphologic and cytochemical properties of mouse liver neoplasms induced by diethylnitrosamine and promoted by 4,4'-dichlorodiphenyltrichloroethane, chlordane, or heptachlor.
Neoplasms
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Neoplasms
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Neoplasms
Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice.
Neoplasms
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Neoplasms
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Neoplasms
Prospects for glycerol-rescued hypoglycemia as a cancer therapy.
Neoplasms
Quantitative evaluation of insulin resistance markers in Pakistani patients suffering from HCV-associated type 2 diabetes mellitus.
Neoplasms
Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney.
Neoplasms
Sequential hepatic histologic and histochemical changes produced by diethylnitrosamine in the rhesus monkey.
Neoplasms
Serum and hepatic enzyme activity in rats treated with diethylnitrosamine.
Neoplasms
Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1?
Neoplasms
The hepatic glucose-6-phosphatase system in Ehrlich-ascites-tumour-bearing mice.
Neoplasms
The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models.
Neoplasms
The Mechanism by Which Amentoflavone Improves Insulin Resistance in HepG2 Cells.
Neoplasms
Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.
Neoplasms
Tumor Formation in Liver of Conditional {beta}-Catenin-Deficient Mice Exposed to a Diethylnitrosamine / Phenobarbital Tumor Promotion Regimen.
Neoplasms
Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat.
Neoplasms
Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro.
Neoplasms
Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.
Neoplasms
Ultracytochemical localization of glucose-6-phosphatase in Chang rat hepatoma in vivo and in vitro.
Neoplasms
Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.
Neoplasms
von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
Neoplasms
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
Neoplasms
[Carbohydrate metabolism enzymatic activity and its alteration under the influence of thyroid hormone during tumor growth]
Neoplasms
[Changes of hepatic glycogen, lactic acid, glucose-6-phosphatase activity and succinate dehydrogenase in the sourse of tumor development under the influence of B thymus extract]
Neoplasms
[Definition and classification of hyperuricemia]
Neoplasms
[FDG-PET in hepatocellular carcinoma. Based on one case]
Neoplasms
[Fibrolamellar liver carcinoma]
Neoplasms
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]
Neoplasms
[Glucose-6-phosphatase activity in experimental tumors and leucocytes of human leukemias.]
Neoplasms
[Glucose-6-phosphatase and aldolase in primary liver tumors induced by diethylnitrosamine]
Neoplasms
[Lipid dependence of nuclear glucose-6-phosphatase in the tumor growth process and the change in its nature after the irradiation of tumor carriers]
Neoplasms
[Posthepatic obstructive jaundice caused by primary extragonadal germ-cell tumor in a patient with glucose-6-phosphatase dehydrogenase deficiency].
Neoplasms
[Properties and isoenzyme contents of glucose-6-phosphatase of normal and tumor cell microsomes]
Neoplasms
[Subcellular particles in tumors. I. Intracellular distribution of cytochrome oxidase, glucose-6-phosphatase, catalase, and several acid hydrolases in a transplantable chemically induced heatoma (hepatoma HW)]
Neoplasms
[The role of arecoline on hepatic insulin resistance in type 2 diabetes rats].
Neoplasms
[Various enzymes of isolated nuclear membranes and cell nuclei of the liver and hepatoma 27 of rats]
Neuroblastoma
Glucose-6-phosphatase-? participates in dopaminergic differentiation.
Neuroblastoma
Inhibition of Glycogen Synthase Kinase-3? by Falcarindiol Isolated from Japanese Parsley (Oenanthe javanica).
Neuroblastoma
[Rapid simultaneous isolation of microsomes and plasma membranes from neuroblastoma C 1300 N 18 cells]
Neuroendocrine Tumors
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Neutropenia
A case of syndromic neutropenia and mutation in G6PC3.
Neutropenia
A novel G6PC3 gene mutation in a patient with severe congenital neutropenia.
Neutropenia
A novel G6PC3 gene mutation in severe congenital neutropenia: pancytopenia and variable bone marrow phenotype can also be part of this syndrome.
Neutropenia
A Severe Congenital Neutropenia Type 4 Case (G6PC3 Mutation) Presented With Large Platelets in the Peripheral Smear.
Neutropenia
A syndrome with congenital neutropenia and mutations in G6PC3.
Neutropenia
Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype.
Neutropenia
Amyloidosis in a Patient With Congenital Neutropenia Because of G6PC3 Deficiency.
Neutropenia
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Neutropenia
Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: Novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia.
Neutropenia
Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.
Neutropenia
G6PC3 Deficiency: Primary Immune Deficiency Beyond Just Neutropenia.
Neutropenia
G6PC3 mutations cause non-syndromic severe congenital neutropenia.
Neutropenia
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.
Neutropenia
Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells.
Neutropenia
NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
Neutropenia
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Neutropenia
Phenotypic Heterogeneity of Neutropenia and Gastrointestinal Illness Associated with G6PC3 Founder Mutation.
Neutropenia
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Neutropenia
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Neutropenia
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Obesity
Effects of G6pc2 deletion on body weight and cholesterol in mice.
Obesity
Glucose-6-phosphatase activity in the hypothalamus of the ob/ob mouse.
Obesity
Hepatic drug metabolism and the activities of NADPH generating enzymes and glucose-6-phosphatase in phenobarbital treated genetically obese (ob/ob) mice.
Obesity
[STUDY RELATIVE EXPRESSION OF GENES THAT CONTROL GLUCOSE METABOLISM IN THE LIVER IN MICE WITH DEVELOPMENT OF MELANOCORTIN OBESITY].
Obesity, Abdominal
Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver.
Ovarian Neoplasms
Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer.
Ovarian Neoplasms
Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.
pantoate-beta-alanine ligase (amp-forming) deficiency
Disorders associated with purine and pyrimidine metabolism.
Parasitic Diseases
Activity of some hydrolytic enzymes in tissue homogenates and haemolymph of fresh water snails, intermediate hosts in schistosomiasis.
Persistent Infection
Changes in catalase and glucose-6-phosphatase distribution patterns within oval cell compartment as possible differentiation markers during viral hepatocarcinogenesis in woodchucks.
Plague
[Activity of alpha-amylase and glucose-6-phosphatase in the liver and blood sugar level in animals infected with plague]
Polyuria
The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver.
Polyuria
[Fundamental and applied studies on transport and metabolism of electrolytes and glucose--aim to contact with molecular biology]
pullulanase deficiency
The molecular background of glycogen metabolism disorders.
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
Renal Insufficiency
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Renal Insufficiency
Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Iotaa.
Reperfusion Injury
Effect of ischemia-reperfusion on the heterogeneous lobular distribution pattern of glycogen content and glucose-6-phosphatase activity in human liver allograft.
Reperfusion Injury
Histoenzymatic study of human renal tissue preservation: I--Proximal tubular glucose-6-phosphatase is correlated with transplant evolution.
Respiratory Distress Syndrome
Early detection of metabolic abnormalities in preterm infants impaired by disorders of blood glucose concentrations.
Reye Syndrome
Reye's syndrome: preservation of mitochondrial enzymes in brain and muscle compared with liver.
Rhabdomyosarcoma
Construction and characterization of a conditionally active construct of the insulin-regulated forkhead transcription factor FKHR.
Rickets
[Liver & kidney glucose-6-phosphatase in experimental rickets in rat & the effect of vitamin D.]
Sarcoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Sarcoma
Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat.
Sarcoma, Avian
Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies.
Schistosomiasis
Activity of some hydrolytic enzymes in tissue homogenates and haemolymph of fresh water snails, intermediate hosts in schistosomiasis.
Schistosomiasis mansoni
Effect of praziquantel on some aspects of carbohydrate metabolism in mice infected with Schistosoma mansoni.
Schistosomiasis mansoni
Ultrastructural cytochemistry of glucose 6-phosphatase in experimental prepatent Schistosomiasis mansoni.
Sepsis
Alterations in glucose-6-phosphatase gene expression in sepsis.
Sepsis
Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat.
Sepsis
Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity.
Siderosis
[Induction, characterization and isolation of preneoplastic hepatocytes following combined treatment with 2-acetaminofluorene and ferric nitrilotriacetate]
Silicosis
[Biochemical investigations of the silicosis problem; enzyme inhibition by silicic acid in the case of microsomal glucose-6-phosphatase.]
Skin Abnormalities
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Sleep Deprivation
Rapid eye movement sleep-deprivation-induced changes in glucose metabolic enzymes in rat brain.
Starvation
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.
Starvation
A novel amino acid signaling process governs glucose-6-phosphatase transcription.
Starvation
Abnormal expression of glucose-6-phosphatase in preterm infants.
Starvation
Age-dependent glycolysis and gluconeogenesis enzyme activities in starved-refed rats.
Starvation
Comparison between starvation and consumption of a high protein diet: plasma insulin and glucagon and hepatic activities of gluconeogenic enzymes during the first 24 hours.
Starvation
Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation.
Starvation
Effect of starvation on fructose diphosphatase, glucose-6-phosphatase and phosphoglucomutase activities in organs of Pseudemys (Chrysemys) scripta elegans.
Starvation
Effect of tumor necrosis factor on enzymes of gluconeogenesis in the rat.
Starvation
Fuel utilization in colonocytes of the rat.
Starvation
Glucose phosphorylation and dephosphorylation in chicken liver.
Starvation
Glucose-6-phosphatase mRNA levels in kidney isolated tubule suspensions are increased by dexamethasone and decreased by insulin.
Starvation
Hypoglycemic effects of Coccinia indica: inhibition of key gluconeogenic enzyme, glucose-6-phosphatase.
Starvation
In situ kinetic parameters of glucose-6-phosphatase in the rat liver lobulus.
Starvation
Molecular cloning of hepatic glucose-6-phosphatase catalytic subunit from gilthead sea bream (Sparus aurata): response of its mRNA levels and glucokinase expression to refeeding and diet composition.
Starvation
Nutritional regulation of glucose-6-phosphatase gene expression in liver of the gilthead sea bream (Sparus aurata).
Starvation
Quantitative aspects of relationship between glucose 6-phosphate transport and hydrolysis for liver microsomal glucose-6-phosphatase system. Selective thermal inactivation of catalytic component in situ at acid pH.
Starvation
Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase.
Starvation
Role of small leucine zipper protein in hepatic gluconeogenesis and metabolic disorder.
Starvation
Sex-specific regionality of liver metabolism during starvation; with special reference to the heterogeneity of the lobular periphery.
Starvation
Significance of the increase in glucose 6-phosphatase activity in skeletal muscle cells of the mouse by starvation.
Starvation
The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism.
Starvation
The glucose-6-phosphatase system.
Starvation
The regulation of serine dehydratase and glucose-6-phosphatase in hyperplastic nodules of rat liver during diethylnitrosamine and N-2-fluorenylacetamide feeding.
Starvation
[Enzyme activity of gluconeogenesis in dietary thiamine deficiency]
Starvation
[Late manifestations of glycogenosis 1 in early adulthood]
Stomach Neoplasms
Ultrastructural cytochemical study of enzymes expressed by signet ring cells in gastric cancer.
Stomach Neoplasms
Ultrastructural cytochemistry of human gastric cancer: electron microscopic observations of five organellae marker enzymes.
Stroke
Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia.
Thrombocytopenia
Phenotypic Heterogeneity of Neutropenia and Gastrointestinal Illness Associated with G6PC3 Founder Mutation.
Thyrotoxicosis
Role of a gitogenin-type steroidal saponin (3-O-?-d-glucopyranosyl (1?2)-?-d-glucopyranosyl (1?4)-?-d-galactopyranoside-25R,5?-spirostane-2?,3?-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats.
Thyrotoxicosis
[Certain indicators of carbohydrate metabolism and functional state of the islands of Langerhans in thyrotoxicosis]
Thyrotoxicosis
[Serum glucose-6-phosphatase activity in thyrotoxicosis patients both fasting and following a sugar load]
Tuberculosis
Glucose-6-phosphatase activity in experimental tuberculosis and following isoniazid treatment.
Urinary Bladder Neoplasms
[Histochemical investigations on human bladder cancer (author's transl)]
Urogenital Abnormalities
A novel G6PC3 gene mutation in a patient with severe congenital neutropenia.
Urogenital Abnormalities
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Virus Diseases
[Metabolic aspects of hepatic tissue in MHV-3 virus infections of the mouse. III. Glucose-6-phosphatase activity.]
Vitamin B 12 Deficiency
[Glucose-6-phosphatase activity in the rat liver in vitamin B12 deficiency.]
Vitamin E Deficiency
Cellular membranes and membrane-bound enzymes in vitamin E deficiency. A histochemical, cytochemical, biochemical, and morphologic study of the liver of the Pekin duckling.
[protein-pii] uridylyltransferase deficiency
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.